RECOMBINATE 500 IU

Negara: Israel

Bahasa: Inggris

Sumber: Ministry of Health

Bahan aktif:

COAGULATION FACTOR VIII RECOMBINANT 500 IU/VIAL

Tersedia dari:

TEVA MEDICAL MARKETING LTD.

Kode ATC:

B02BD05

Bentuk farmasi:

POWDER FOR SOLUTION FOR INJECTION

Rute administrasi :

I.V

Diproduksi oleh:

BAXTER S.A., BELGIUM

Kelompok Terapi:

COAGULATION FACTOR VII

Indikasi Terapi:

The use of Recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Recombinate is also indicated in the perioperative management of patients with haemophilia A. Recombinate is appropriate for use in children of all ages including the newborn. (Safety and efficacy studies have been performed in both previously treated and previously untreated children). The product in not suitable for the treatment of von Willebrand's disease.

Tanggal Otorisasi:

2010-07-01